Neoprol Overview

  • Founded
  • 2014

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 1

Neoprol General Information


Developer of medical formulations designed to focus on the preparation of anesthesia drugs. The company's medical formulations offer the development of propofol product that is used for intravenous induction and maintenance of anesthesia, enabling patients to avoid any side effects of anesthesia.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Givat Ram
  • Jerusalem
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neoprol Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 01-Mar-2019 Completed Generating Revenue
To view Neoprol’s complete valuation and funding history, request access »

Neoprol Executive Team (1)

Name Title Board Seat Contact Info
Nissim Garti Founder & Chief Executive Officer
To view Neoprol’s complete executive team members history, request access »

Neoprol Board Members (1)

Name Representing Role Since
Yatindra Joshi Neoprol Chairman 000 0000
To view Neoprol’s complete board members history, request access »

Neoprol Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Integra Holdings Venture Capital Minority 000 0000 000000 0
To view Neoprol’s complete investors history, request access »